User profiles for G. Sotgiu

Giovanni Sotgiu

University of Sassari
Verified email at uniss.it
Cited by 30236

Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis

M Sester, G Sotgiu, C Lange, C Giehl… - European …, 2011 - Eur Respiratory Soc
… TB®, QFT-G-IT and TST in this analysis were as low as 59%, 79% and 75%, respectively.
Unlike previous reports on the specificity of IGRAs for the diagnosis of TB that have exclusively …

Towards tuberculosis elimination: an action framework for low-incidence countries

…, A Smith-Palmer, G Sotgiu, G Sulis… - European …, 2015 - Eur Respiratory Soc
This paper describes an action framework for countries with low tuberculosis (TB) incidence
(<100 TB cases per million population) that are striving for TB elimination. The framework …

Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries

…, HJ Schünemann, SK Sharma, G Sotgiu… - European …, 2015 - Eur Respiratory Soc
Latent tuberculosis infection (LTBI) is characterised by the presence of immune responses
to previously acquired Mycobacterium tuberculosis infection without clinical evidence of …

Official American thoracic society/centers for disease control and prevention/infectious diseases society of America clinical practice guidelines: treatment of drug …

…, J Saukkonen, HS Schaaf, G Sotgiu… - Clinical infectious …, 2016 - academic.oup.com
The American Thoracic Society, Centers for Disease Control and Prevention, and Infectious
Diseases Society of America jointly sponsored the development of this guideline for the …

[HTML][HTML] Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients

…, SS Shin, Y Shiraishi, J Sifuentes-Osornio, G Sotgiu… - 2012 - journals.plos.org
Background Treatment of multidrug resistant tuberculosis (MDR-TB) is lengthy, toxic,
expensive, and has generally poor outcomes. We undertook an individual patient data meta-…

Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases

…, D Visca, MZ Murguiondo, G Sotgiu… - European …, 2020 - Eur Respiratory Soc
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19)
pandemic has attracted interest because of its global rapid spread, clinical severity, high …

[HTML][HTML] Control of confounding and reporting of results in causal inference studies. Guidance for authors from editors of respiratory, sleep, and critical care journals

…, RE Russell, A Sheikh, G Sotgiu… - Annals of the …, 2019 - atsjournals.org
The views and recommendations made in this document do not represent the official position
of any publisher or professional medical society. This document has not been endorsed by …

[HTML][HTML] Tuberculosis and COVID-19 interaction: a review of biological, clinical and public health effects

…, J Mueller, P Mueller, R Duarte, M Dalcolmo, G Sotgiu… - Pulmonology, 2021 - Elsevier
Evidence is accumulating on the interaction between tuberculosis (TB) and COVID-19. The
aim of the present review is to report the available evidence on the interaction between these …

Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis

JA Caminero, G Sotgiu, A Zumla… - The Lancet infectious …, 2010 - thelancet.com
Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis are generally
thought to have high mortality rates. However, many cases can be treated with the right …

Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis

…, TS Shim, R Singla, SE Smith, G Sotgiu, G Sukhbaatar… - The Lancet, 2018 - thelancet.com
Background Treatment outcomes for multidrug-resistant tuberculosis remain poor. We aimed
to estimate the association of treatment success and death with the use of individual drugs, …